|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/13/19 Emmaus Life Sciences, Inc. S-4 77:12M S2 Filings LLC/FA |
Document/Exhibit Description Pages Size
1: S-4 Registration of Securities Issued in a HTML 4.11M
Business-Combination Transaction
2: EX-23.1 Consent of Experts or Counsel HTML 21K
3: EX-23.2 Consent of Experts or Counsel HTML 20K
4: EX-23.4 Consent of Experts or Counsel HTML 21K
9: EX-99.11 Miscellaneous Exhibit HTML 21K
5: EX-99.6 Miscellaneous Exhibit HTML 21K
6: EX-99.7 Miscellaneous Exhibit HTML 21K
7: EX-99.8 Miscellaneous Exhibit HTML 21K
8: EX-99.9 Miscellaneous Exhibit HTML 21K
16: R1 Document and Entity Information HTML 43K
17: R2 Consolidated Balance Sheets HTML 126K
18: R3 Consolidated Balance Sheets (Parenthetical) HTML 49K
19: R4 Consolidated Statements of Operations HTML 79K
20: R5 Consolidated Statements of Changes in Equity HTML 104K
21: R6 Consolidated Statements of Cash Flows HTML 119K
22: R7 Consolidated Statements of Cash Flows HTML 24K
(Parenthetical)
23: R8 Nature of Operations HTML 32K
24: R9 Summary of Significant Accounting Policies HTML 80K
25: R10 Accounts Receivable, Net HTML 27K
26: R11 Long - Term Borrowings and Other Note Payables HTML 27K
27: R12 Acquisition HTML 47K
28: R13 Stockholders' Equity HTML 189K
29: R14 Convertible Preferred Stock HTML 40K
30: R15 Income Taxes HTML 67K
31: R16 Related Party Transactions HTML 30K
32: R17 Loss Per Share HTML 38K
33: R18 Commitments and Contingent Liabilities HTML 33K
34: R19 Significant Customers HTML 23K
35: R20 Subsequent Events HTML 32K
36: R21 Summary of Significant Accounting Policies HTML 162K
(Policies)
37: R22 Summary of Significant Accounting Policies HTML 26K
(Tables)
38: R23 Accounts Receivable, Net (Tables) HTML 28K
39: R24 Acquisition (Tables) HTML 47K
40: R25 Stockholders' Equity (Tables) HTML 157K
41: R26 Income Taxes (Tables) HTML 67K
42: R27 Loss Per Share (Tables) HTML 37K
43: R28 Commitments and Contingent Liabilities (Tables) HTML 28K
44: R29 Nature of Operations (Details Narrative) HTML 32K
45: R30 Summary of Significant Accounting Policies HTML 33K
(Details )
46: R31 Summary of Significant Accounting Policies HTML 31K
(Details Narrative)
47: R32 Summary of Significant Accounting Policies HTML 71K
(Details Narrative 1)
48: R33 Accounts Receivable, Net (Details) HTML 29K
49: R34 Long - Term Borrowings and Other Note Payables HTML 49K
(Details Narrative)
50: R35 Acquisition (Details) HTML 67K
51: R36 Acquisition (Details 1) HTML 30K
52: R37 Acquisition (Details Narrative) HTML 57K
53: R38 Stockholders' Equity (Details) HTML 34K
54: R39 Stockholders' Equity (Details 1) HTML 28K
55: R40 Stockholders' Equity (Details 2) HTML 56K
56: R41 Stockholders' Equity (Details 3) HTML 124K
57: R42 Stockholders' Equity (Details 4) HTML 50K
58: R43 Stockholders' Equity (Details 5) HTML 34K
59: R44 Stockholders' Equity (Details 6) HTML 43K
60: R45 Stockholders' Equity (Details 7) HTML 63K
61: R46 Stockholders' Equity (Details Narrative) HTML 215K
62: R47 Stockholders' Equity (Details Narrative 1) HTML 101K
63: R48 Convertible Preferred Stock (Details Narrative) HTML 59K
64: R49 Income Taxes (Details) HTML 45K
65: R50 Income Taxes (Details 1) HTML 41K
66: R51 Income Taxes (Details 2) HTML 44K
67: R52 Income Taxes (Details 3) HTML 42K
68: R53 Income Taxes (Details Narrative) HTML 37K
69: R54 Related Party Transactions (Details Narrative) HTML 61K
70: R55 Loss Per Share (Details) HTML 48K
71: R56 Commitments and Contingent Liabilities (Details) HTML 25K
72: R57 Commitments and Contingent Liabilities (Details HTML 43K
Narrative)
73: R58 Significant Customers (Details Narrative) HTML 31K
74: R59 Subsequent Events (Details Narrative) HTML 60K
76: XML IDEA XML File -- Filing Summary XML 131K
75: EXCEL IDEA Workbook of Financial Reports XLSX 100K
10: EX-101.INS XBRL Instance -- mynd-20180930 XML 1.81M
12: EX-101.CAL XBRL Calculations -- mynd-20180930_cal XML 199K
13: EX-101.DEF XBRL Definitions -- mynd-20180930_def XML 782K
14: EX-101.LAB XBRL Labels -- mynd-20180930_lab XML 1.28M
15: EX-101.PRE XBRL Presentations -- mynd-20180930_pre XML 1.00M
11: EX-101.SCH XBRL Schema -- mynd-20180930 XSD 198K
77: ZIP XBRL Zipped Folder -- 0001615774-19-002408-xbrl Zip 173K
Exhibit 99.7
MYnd Analytics, Inc.
26522 La Alameda, Suite 290
Consent to Reference in Joint Proxy Statement/Prospectus
MYnd Analytics, Inc. (the “Company”) is filing a Registration Statement on Form S-4 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”). In connection therewith, I hereby consent, pursuant to Rule 438 of the Securities Act, to the reference to me in the joint proxy statement/prospectus included in such Registration Statement as a future member of the board of directors of the Company, such appointment to commence upon the closing of the transactions described in the joint proxy statement/prospectus.
| Sincerely, | |
| /s/ Willis C. Lee | |
| Willis C. Lee, M.S. |
C:
| This ‘S-4’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 2/13/19 | None on these Dates | ||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/25/19 SEC UPLOAD¶ 7/10/19 2:39K Emmaus Life Sciences, Inc. |